Preventing Chronic Disease | Ohio Primary Health Care Providers’ Practices and Attitudes Regarding Screening Women With Prior Gestational Diabetes for Type 2 Diabetes Mellitus — 2010 - CDC
Ohio Primary Health Care Providers’ Practices and Attitudes Regarding Screening Women With Prior Gestational Diabetes for Type 2 Diabetes Mellitus — 2010
Loren Rodgers, PhD; Elizabeth J. Conrey, PhD, RD; Andrew Wapner, DO, MPH; Jean Y. Ko, PhD; Patricia M. Dietz, DrPH; Reena Oza-Frank, PhD, RD
Suggested citation for this article: Rodgers L, Conrey EJ, Wapner A, Ko JY, Dietz PM, Oza-Frank R. Ohio Primary Health Care Providers’ Practices and Attitudes Regarding Screening Women With Prior Gestational Diabetes for Type 2 Diabetes Mellitus — 2010. Prev Chronic Dis 2014;11:140308. DOI: http://dx.doi.org/10.5888/pcd11.140308
.
.PEER REVIEWED
Abstract
Introduction
Gestational diabetes mellitus (GDM) is associated with a 7-fold increased lifetime risk for developing type 2 diabetes mellitus. Early diagnosis of type 2 diabetes is crucial for preventing complications. Despite recommendations for type 2 diabetes screening every 1 to 3 years for women with previous diagnoses of GDM and all women aged 45 years or older, screening prevalence is unknown. We sought to assess Ohio primary health care providers’ practices and attitudes regarding assessing GDM history and risk for progression to type 2 diabetes.
Gestational diabetes mellitus (GDM) is associated with a 7-fold increased lifetime risk for developing type 2 diabetes mellitus. Early diagnosis of type 2 diabetes is crucial for preventing complications. Despite recommendations for type 2 diabetes screening every 1 to 3 years for women with previous diagnoses of GDM and all women aged 45 years or older, screening prevalence is unknown. We sought to assess Ohio primary health care providers’ practices and attitudes regarding assessing GDM history and risk for progression to type 2 diabetes.
Methods
During 2010, we mailed surveys to 1,400 randomly selected Ohio family physicians and internal medicine physicians; we conducted analyses during 2011–2013. Overall responses were weighted to adjust for stratified sampling. Chi-square tests compared categorical variables.
During 2010, we mailed surveys to 1,400 randomly selected Ohio family physicians and internal medicine physicians; we conducted analyses during 2011–2013. Overall responses were weighted to adjust for stratified sampling. Chi-square tests compared categorical variables.
Results
Overall response rate was 34% (380 eligible responses). Among all respondents, 57% reported that all new female patients in their practices are routinely asked about GDM history; 62% reported screening women aged 45 years or younger with prior GDM every 1 to 3 years for glucose intolerance; and 42% reported that screening for type 2 diabetes among women with prior GDM is a high or very high priority in their practice.
Overall response rate was 34% (380 eligible responses). Among all respondents, 57% reported that all new female patients in their practices are routinely asked about GDM history; 62% reported screening women aged 45 years or younger with prior GDM every 1 to 3 years for glucose intolerance; and 42% reported that screening for type 2 diabetes among women with prior GDM is a high or very high priority in their practice.
Conclusion
Because knowing a patient’s GDM history is the critical first step in the prevention of progression to type 2 diabetes for women who had GDM, suboptimal screening for both GDM history and subsequent glucose abnormalities demonstrates missed opportunities for identifying and counseling women with increased risk for type 2 diabetes.
Because knowing a patient’s GDM history is the critical first step in the prevention of progression to type 2 diabetes for women who had GDM, suboptimal screening for both GDM history and subsequent glucose abnormalities demonstrates missed opportunities for identifying and counseling women with increased risk for type 2 diabetes.
Acknowledgments
We thank Sherry Farr, PhD; Cheryl L. Robbins, PhD; Cynthia Shellhaas, MD, MPH; Norma Ryan, PhD, RN; Gwen Stacey, RD; Thomas Joyce, MA; Jessica Londeree, MPH; Katherine Meagley, MPH; and Monica Hunsberger, PhD, MPH, RD, LD, for their contributions toward the design of the health care provider survey. This work was supported solely through regular institution operating funds.
Author Information
Corresponding Author: Loren E. Rodgers, PhD, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, MS A-19, 1600 Clifton Rd NE, Atlanta, GA 30329. Telephone: 404-718-4835. E-mail: lrodgers@cdc.gov. Dr Rodgers is also affiliated with the Ohio Department of Health, Columbus, Ohio.
Author Affiliations: Elizabeth J. Conrey, Centers for Disease Control and Prevention, Atlanta, Georgia, and Ohio Department of Health, Columbus, Ohio; Andrew Wapner, Ohio Department of Health, Columbus, Ohio; Jean Y. Ko, Patricia M. Dietz, Centers for Disease Control and Prevention, Atlanta, Georgia; Reena Oza-Frank, Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, and Ohio State University, Columbus, Ohio.
No hay comentarios:
Publicar un comentario